ArticleOncotarget2017

Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.

Gloria Bonuccelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.